Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Prognostic and predictive biomarkers to cyclin-dependent kinases 4 and 6 inhibitors are lacking. Circulating tumor DNA (ctDNA) can be used to profile these patients and dynamic changes in ctDNA could be an early predictor of treatment efficacy. Here, we conducted plasma ctDNA profiling in patients f...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | CLINICAL CANCER RESEARCH
29 No. 20 |
| Tárgyszavak: | |
| doi: | 10.1158/1078-0432.CCR-23-0956 |
| mtmt: | 34513250 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/29342 |